EW Stock Summary and Trading Ideas (Edwards Lifesciences | NYSE:EW)

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Edwards Lifesciences trades on the NYSE stock market under the symbol EW.

As of December 15, 2025, EW stock price climbed to $83.38 with 3,619,692 million shares trading.

EW has a beta of 0.46, meaning it tends to be less sensitive to market movements. EW has a correlation of 0.12 to the broad based SPY ETF.

EW has a market cap of $48.39 billion. This is considered a Large Cap stock.

Last quarter Edwards Lifesciences reported $2 billion in Revenue and $.67 earnings per share. This beat revenue expectation by $55 million and exceeded earnings estimates by $.08.

In the last 3 years, EW traded as high as $96.12 and as low as $58.93.

The top ETF exchange traded funds that EW belongs to (by Net Assets): VTI, VOO, VO, SPY, IVV.

EW has underperformed the market in the last year with a price return of +12.7% while the SPY ETF gained +13.8%. However, in the short term, EW had mixed performance relative to the market. It has outperformed in the last 3 months, returning +7.5% vs +3.8% return in SPY. But in the last 2 weeks, EW shares have been beat by the market, returning -3.8% compared to an SPY return of -0.4%.

EW support price is $81.83 and resistance is $84.33 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EW shares will trade within this expected range on the day.